GSK Pharma delivered a better-than-expected performance in Q3, largely driven by robust volume growth in the general medicine ...

GlaxoSmithKline (GSK – Research Report ... being broadly in line with consensus but showing signs of weakness in the vaccine segment. This is attributed to disappointing performances from ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.80. The company’s ...

Pharmaceutical giant GlaxoSmithKline will buy the oncology biotech company ... Endpoints News notes that Zejula is one of several PARP inhibitors that have reached the market, after AstraZeneca gained ...

United States, New York, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research reports that the Analgesics Market around the world was USD 87.59 billion in 2023 and it was projected to ...

DUBLIN--(BUSINESS WIRE)--The "Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis ...

For further results highlights, click. GlaxoSmithKline Pharma has been benefitting from rising market share for its antibiotic Augmentin and respiratory drugs Nucala and Trelegy. Strong demand for ...

BURLINGAME, CA, UNITED STATES, January 15, 2025 /EINPresswire / -- Latest Report, titled“Herpes Simplex Virus (Hsv) Vaccines Market” Trends, Share, Size, Growth, Opportunity and Forecast 2025 ...